dukederm.duke.edu  
   

Celebrating 70 Years
Over 130 friends and alumni of Duke Dermatology gathered on October 19 – 21, 2007 to celebrate our 70th anniversary of Dr. Cal’s starting Duke Dermatology and to celebrate the outstanding career of Dr. Sheldon Pinnell, J. Lamar Callaway Professor of Dermatology, Emeritus.
 
 
 
 
 
 
On July 1, 1937 Dr. J. Lamar Callaway returned to Duke University School of Medicine to become the head of Dermatology. Dr. Cal was 26 years old and remained head of the Division of Dermatology until 1975. July 1, 2007 is the 70th anniversary of Duke Dermatology.
 
 
Why Choose a Duke Residency?
The close integration of clinical and basic science activities provides a solid foundation in the fundamentals of dermatologic pathophysiology as they are applied to patient care.

The goal of the residency program in Dermatology at Duke University Medical Center is to train physicians to become excellent clinical dermatologists and leaders in academic and clinical dermatology.
 

More »

Faculty & Resident in the News

Dr. Kelly Nelson was recently interviewed on NBC Nightly News regarding her studies utilizing the new technology of real time confocal microscopy for the diagnosis of skin cancers. This technology holds the promise of offering early diagnosis of skin cancers including malignant melanoma, without the use of an invasive skin biopsy. Studies are underway to determine how this new technique can be used to benefit patients with earlier diagnosis and treatment of skin cancers

 
 

Duke Dermatology was active at the recent national meeting of the Society for Investigative Dermatology held May 6 - 9 in Montreal, Canada.

Dr. Jennifer Zhang's lab presented work on the molecular mechanisms that control the development of skin cancer. (link to abstracts) In addition, Dr. Zhang chaired the session on Growth Factors and Signal Transduction.  Dr. Robert Walters presented his work on the molecular mechanisms of the facial flushing associated with the use of niacin, an important drug used to treat elevated blood lipids.  Dr. Heather Yeowell presented her work on the mechanisms of increased lysyl hydroxylase 2 long form that is found in scleroderma, which may suggest new therapies for scleroderma.  Dr. Russell Hall  presented his work on the use of new anti-B cell therapies for the treatment of bullous pemphigoid and for the changes in B cells that occur with this treatment.

Dr. Robert Walters has reported in the Journal of Clinical Investigation on his findings that the facial flushing which occurs with ingestion of the drug Niacin is mediated by beta arrestin 1 signaling. The advantageous lipid lowering effect of the drug is not mediated via this mechanism.  News 14 picked up the story

Dr Robert Walters  was awarded a Dermatology Foundation Physician Scientist Career Develompment Award (complete list of award recipients) for his work on Beta Arrestin mediated signaling. 

Dr. Walters was also awarded a grant by the National Rosacea Society for his study on the regulation of flushing by beta arrestin mediated signaling.

Dr. Puneet Seth, Ph.D, a Research Associate in Duke Dermatology, has recently been awarded a Postdoctoral Travel Fellowship by the American Society for Biochemistry and Molecular Biology (ASBMB).

Dr. Seth was awarded this prestigious Travel Fellowship to present his latest data in scleroderma research carried out in Dr. Heather Yeowell's research laboratory.  This work is funded by the National Institute of Aging and Scleroderma Foundation Grants to Prof. Yeowell (Principal Investigator) and will be presented at the ASBMB Annual Meeting in New Orleans , LA in April 2009.

Dr. Jennifer Zhang , PhD, received an award from the Skin Cancer Foundation for a project testing the feasibility of targeting c-Jun and c-Fos for skin cancer treatment.

 
 
 
 
 
 
 
First Annual Fred Blum (HS 1986-1989) Lectureship delivered by Dr. Lisa Beck (HS 1987-1990)
 
Duke Dermatology lost a great friend with the death of Dr. Fred Blum on October 17, 2008.  Fred completed his residency in Dermatology at Duke in 1989 and practiced dermatology in Durham, most recently with Duke Dermatology graduates Drs. Lori Etter, Craig Heinly and Steve Higgins.  Fred was committed to teaching and learning about dermatology.  He was an active volunteer teacher at the Durham VA Medical Center and recruited other outstanding dermatologist to participate in our teaching program at the VA.  Fred was also an enthusiastic participant in our monthly Duke UNC Clinical Conferences, asking probing questions and relishing the camaraderie that is so typical of dermatology in our community.
 
In honor of Fred and his commitment to learning and dermatology we have established the Fred Blum Lectureship in Dermatology at Duke.  We were honored to have as our first Blum Lecturer a residency class mate of Fred’s,  Dr. Lisa Beck, Associate Professor of Dermatology,  University of Rochester.  Dr. Beck is a world expert in dermatologic allergy including urticaria and atopy.  Her lecture with practical tips and the latest scientific advances was typical of what excited Fred about the never ending enjoyment in learning dermatology.  We are raising funds to support this lectureship in perpetuity so that all future Duke residents and community dermatologists will remember the enthusiasm, the joy of learning and the commitment to outstanding patient care that marked Fred’s career in dermatology.  Contributions to the Fred Blum Lectureship in Dermatology can be made by sending your tax deductible contributions to Duke Dermatology, Box 3135, Duke University Medical Center Durham, NC, 27710.
 

MORE NEWS>>

 
News/Links
Welcome to the Department of Dermatology at Duke University Medical Center. Duke Dermatology has a long tradition that began when Dr. J. Lamar Callaway founded the Division in 1939.
 
Our Vision
 
RUSSELL P. HALL, MD, Division Chief
Dr. Russell P Hall, III
 
J. Lamar Callaway Professor and Chair
Duke Dermatology: Teaching, Investigating and Caring.
Reflections from the Chair
 
 

New Faculty

 
Priya Venkatesan, MD
(July 2009)
 
Jane Bellet, MD
(February 2009)
 
 
Caroline Rao, MD.,
(September 2008)
 
Amber Atwater, MD.,
(August 2008)
 
 
 
Links of Interest:
 
 
 
 
 
May 14, 2009
2-6pm rm 3031 Purple Duke South
 
"Innate Immunity: Its role in acne pathogenesis and defense"
 
 
 
Recent Publications
1.    Olsen EA, Kim YH, Kuzel TM, Pacheco TR, Foss FM et al.:  A Phase IIb multicenter trial of Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in patients with persistent, progressive or treatment refractory mycosis fungoides or Sézary Syndrome subtypes of cutaneous T-cell lymphoma.  J Clin Oncol; 25(21): 3109-3115, 2007.
 
2.    Olsen EA, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, et al.:  Revisions to the staging and classification of mycosis fungoides and Sezary Syndrome:  a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Study Group of the European Organization of Research and Treatment of Cancer (EORTC).  Blood; 110(6): 1708-1709, 2007.
 
3.    Zhang JY, Adams AE, Ridky TW, Tao S, Khavari PA. Tumor necrosis factor receptor 1/c-Jun-NH2-Kinase signaling promotes human neoplasia. Cancer Research 67: 3827-34, 2007.
 
4.    Hall RP, Benbenisty KM, Mickle C, Takeuchi F, Streilein, RD. Serum IL-8 in patients with dermatitis herpetiformis (DH) is produced in response to dietary gluten. J Invest Dermatol    127:2158-65,2007
 
5.    Stryjewski ME, Hall RP, Chu VH, Kanafani ZA, O’Rioran WD, Weinstock M, Stienecker RS, Streilein RD, Dorschner RA, Fowler Jr VG, Corey GR, Gallo RL.  Expression of antimicrobial peptides in normal and infected skin of patients with infective cellulitis. J Infect Dis  196:1425-30, 2007.
 
6.    Berkowitz P, Diaz L.A., Hall RP, Rubenstein DS.  Induction of p38MAPK and HSP27 phosphorylation in pemphigus vulgaris patient skin. J Invest Dermatol   128: 738-740, 2007.
 
7.    Kim YH, Willemze R, Pimpinelli N, Whittaker S, Olsen EA, Ranki A, Dummer R, and Hoppe RT for the ISCL and the EORTC:  TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary Syndrome: A proposal of the International Society for Cutaneous Lymphomas(ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC).  Blood 110: 479-484, 2007.
 
8.    Adler AS, Sinha S, Kawahara TL, Zhang JY, Segal E and Chang HA.  Motif map reveals enforcement of aging by continual NF-kB activity. Genes and Dev 21: 3244-3257, 2007.
 
9.    Thomas MW, Grichnik JM, and JA Izatt,  Three-Dimensional Images and Vessel Rendering using optical coherence tomography,  Archives of Dermatology, 143:1468-1469, 2007
 
10.  Giunta, C., Elçioglu, N., Albrecht, B., Eich, G., Chambaz, C., Janecke, A.R., Yeowell, H.N., Eyre, D., Kraenzlin, B., and Steinmann, B. Spondylo-Cheiral Form of the Ehlers-Danlos Syndrome - A Novel Autosomal Recessive Entity Caused by Mutations in the Zinc Transporter Gene SLC39A13. Am. J. Hum. Genet. 82 (6): 1290-1305, 2008
Disclaimer      Duke & Your Privacy      © 2009, Duke University Health System  
DHTS Strategic Web Services DHTS STRATEGIC WEB SERVICES